Using endothelium-specific, ribosome-associated mRNA sequencing to evaluate expression changes in a mouse breast cancer model treated with 6-3-A6, we determined that Notch4 inhibition alters tumor endothelial pathways associated with vascular function. Here, NOTCH4 is linked to breast carcinoma.